Navigation Links
Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
Date:5/23/2008

CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the UBS Global Specialty and Generic Pharmaceuticals Conference on Wednesday, May 28, 2008 at 2:30 p.m. London BST (9:30 a.m. EDT).

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL: http://events.webeventservices.com/ubs/2008/05/28/index.asp.

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Watson to Present at the Bank of America 2008 Healthcare Conference
2. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
3. Watson Files Application for Generic SEASONIQUE(R)
4. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
5. Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
8. Watson to Distribute Alendronate Tablets
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
11. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los Angeles area ... fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. ... in Plastic and Reconstructive Surgery. The candidate will have the opportunity to ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior ... Alzheimer’s Family Center. , Guests will be able to vote for their favorite ... Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek ...
(Date:8/21/2017)... , ... August 21, 2017 , ... The experts have ... are we supposed to get things done in a healthy way these days? FlexiSpot, ... launching a crowdfunding campaign on August 28 to introduce Deskcise Pro™– the world’s first ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon ... reform plan, has announced his candidacy for the 52nd Congressional District currently held by ... America’s Promise. Coming to this country at age eleven after suffering homelessness and hardship ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/26/2017)... -- E.I. Medical Imaging (EIMI) has partnered with Dr. ... the worlds first ultrasound system to be used underwater to ... In preparation for a piece produced by Icon films ... Guttridge approached EIMI with the idea of an underwater ultrasound ... underwater. EIMI produces ...
Breaking Medicine Technology: